Neuroprotection of Pramipexole in UPS Impairment Induced Animal Model of Parkinson’s Disease

Author： Li Chao   Guo Yuan   Xie Wenjie   Li Xingang   Janokovic Joseph   Le Weidong  

Publisher： Springer Publishing Company

ISSN： 0364-3190

Source： Neurochemical Research, Vol.35, Iss.10, 2010-10, pp. : 1546-1556

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

VPS41-mediated neuroprotection in a Caenorhabditis elegans model of Parkinson’s disease

By Tyson Trevor   Brundin Patrik  

Future Neurology, Vol. 7, Iss. 3, 2012-05 ,pp. : 255-258

Future Medicine

Access to resources Recommend Favorite

Cognitive impairment in Parkinson’s disease

By Mindham R.H.S.   Hughes T.A.  

International Review of Psychiatry, Vol. 12, Iss. 4, 2000-11 ,pp. : 281-289

Informa Healthcare

Access to resources Recommend Favorite

The Potential Neuroprotection Mechanism of GDNF in the 6-OHDA-Induced Cellular Models of Parkinson’s Disease

By Li Feng   Wang Meng   Zhu Shuan   Li Li   Xiong Ye   Gao Dian-Shuai  

Cellular and Molecular Neurobiology, Vol. 33, Iss. 7, 2013-10 ,pp. : 907-919

Springer Publishing Company

Access to resources Recommend Favorite

Neuropathology in Parkinson’s disease with mild cognitive impairment

By Jellinger Kurt  

Acta Neuropathologica, Vol. 120, Iss. 6, 2010-12 ,pp. : 829-830

Springer Publishing Company

Access to resources Recommend Favorite

Animal models of Parkinson’s disease progression

By Meredith Gloria   Sonsalla Patricia   Chesselet Marie-Francoise  

Acta Neuropathologica, Vol. 115, Iss. 4, 2008-04 ,pp. : 385-398

Springer Publishing Company

Access to resources Recommend Favorite